cisapride has been researched along with Ache in 3 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomized, double-blind, placebo-controlled study, 32 patients with nonulcer dyspepsia received 5 mg of cisapride or placebo three times daily for four weeks after a two-week run-in phase on placebo." | 9.06 | Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride. ( De Nutte, N; Defrance, P; Van Ganse, W; Witterhulghe, M, 1989) |
| "In a randomized, double-blind, placebo-controlled study, 32 patients with nonulcer dyspepsia received 5 mg of cisapride or placebo three times daily for four weeks after a two-week run-in phase on placebo." | 5.06 | Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride. ( De Nutte, N; Defrance, P; Van Ganse, W; Witterhulghe, M, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rösch, W | 1 |
| Liebregts, T | 1 |
| Gundermann, KJ | 1 |
| Vinson, B | 1 |
| Holtmann, G | 1 |
| Madisch, A | 1 |
| Heydenreich, CJ | 1 |
| Wieland, V | 1 |
| Hufnagel, R | 1 |
| Hotz, J | 1 |
| De Nutte, N | 1 |
| Van Ganse, W | 1 |
| Witterhulghe, M | 1 |
| Defrance, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Peppermint Oil as an Alternative Treatment for Children With Bladder and Bowel Dysfunction: A Prospective Study[NCT05613153] | 30 participants (Anticipated) | Interventional | 2022-11-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cisapride and Ache
| Article | Year |
|---|---|
Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
Topics: Antiemetics; Cisapride; Cohort Studies; Double-Blind Method; Dyspepsia; Gastrointestinal Agents; Hum | 2006 |
2 trials available for cisapride and Ache
| Article | Year |
|---|---|
Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
Topics: Cisapride; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Gastrointestinal Agents; Helic | 1999 |
Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
Topics: Adult; Antacids; Cisapride; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Female; Humans | 1989 |